Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide
- PMID: 9059246
- PMCID: PMC1722112
- DOI: 10.1136/bjo.81.2.130
Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide
Abstract
Background: Optic neuropathy is a rare manifestation of systemic lupus erythematosus (SLE). In a previous series most patients with optic neuropathy in association with SLE had a final visual acuity of 20/200 or less despite corticosteroid therapy.
Methods: Three patients (five affected eyes) with severe retrobulbar optic neuropathy in association with SLE were treated promptly with intravenous cyclophosphamide and corticosteroids.
Results: All patients recovered excellent visual acuity.
Conclusion: Although optic neuropathy in association with SLE might have several different aetiologies, intravenous cyclophosphamide should be strongly considered as a therapeutic alternative.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical